Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Antithrombin Deficiency”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Large-scale testing (Phase 3)Study completedNCT00110513
What this trial is testing

Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery

Who this might be right for
Antithrombin III Deficiency
rEVO Biologics 18
Not applicableNot Yet RecruitingNCT05891899
What this trial is testing

Belgian Antithrombin Deficiency Registry

Who this might be right for
Antithrombin III Deficiency
Universitair Ziekenhuis Brussel 1,000
Not applicableStudy completedNCT04879550
What this trial is testing

Prospective Investigation of Antithrombin III Deficiency in Adult Patients With ECMO

Who this might be right for
Antithrombin III DeficiencyExtracorporeal Membrane Oxygenation Complication
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT04899232
What this trial is testing

Antithrombin III in Infectious Disease Caused by COVID-19

Who this might be right for
Antithrombin III DeficiencyCovid19
Enrique Ginzburg 52
Large-scale testing (Phase 3)Study completedNCT00056550
What this trial is testing

Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.

Who this might be right for
Antithrombin Deficiency, Congenital
rEVO Biologics 14
Large-scale testing (Phase 3)Looking for participantsNCT06096116
What this trial is testing

Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass

Who this might be right for
Acquired Antithrombin Deficiency
Octapharma 120
Early research (Phase 1)Study completedNCT00938288
What this trial is testing

KW-3357 in Congenital Antithrombin Deficiency

Who this might be right for
Congenital Antithrombin Deficiency
Kyowa Kirin Co., Ltd. 16
Large-scale testing (Phase 3)Active Not RecruitingNCT00319228
What this trial is testing

Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate

Who this might be right for
Antithrombin III Deficiency
Grifols Biologicals, LLC 30
Not applicableUnknownNCT02503267
What this trial is testing

"Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects"

Who this might be right for
Congenital Heart DiseasesConotruncal DefectsCongenital Disorder of Glycosylation+1 more
Hospital Universitari Vall d'Hebron Research Institute 300
Large-scale testing (Phase 3)Looking for participantsNCT04918173
What this trial is testing

Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery

Who this might be right for
Congenital Antithrombin Deficiency
Octapharma 38
Post-approval studies (Phase 4)WithdrawnNCT02278575
What this trial is testing

Atenativ Effect on Uterine Blood Flow and Preeclampsia

Who this might be right for
Antithrombin III Deficiency
Vastra Gotaland Region